A randomized, placebo controlled, double blinded, parallel group clinical study to evaluate the efficacy and safety of AEV01 along with standard care for elderly patients with mild COVID-19-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A randomized, placebo controlled, double blinded, parallel group clinical study to evaluate the efficacy and safety of AEV01 along with standard care for elderly patients with mild COVID-19

Published:2024-01 Issue:1 Volume:15 Page:100860
ISSN:0975-9476
Container-title:Journal of Ayurveda and Integrative Medicine
language:en
Short-container-title:Journal of Ayurveda and Integrative Medicine

Author:

Balan Aravinda Kumar,Kannan Ramesh^ORCID,Muralikumar Vanitha^ORCID,Annam Vamseedhar,Murugesan Sakthi Balan,Sekhar MM,Medasani Renu

Publisher

Elsevier BV

Reference31 articles.

1. SARS-CoV-2 infection represents a high risk for the elderly: analysis of pathogenesis;Pedreañez;Arch Virol,2021

2. Influence of immune aging on vaccine responses;Gustafson;J Allergy Clin Immunol,2020

3. AdvisoryforElderlyPopulation, n.d. [Internet]. Available from: https://www.mohfw.gov.in/pdf/AdvisoryforElderlyPopulation.pdf (accessed on August 2023).

4. Traditional Chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARS-CoV-2): a review and perspective;Yang;Int J Biol Sci,2020

5. Ongoing clinical trials for the management of the COVID-19 pandemic;Lythgoe;Trends Pharmacol Sci,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP